Mystic Pharmaceuticals’ Intranasal Technology Introduces Solutions In Drug Delivery
Delivery of drugs and vaccines via the nose offer many compelling advantages including reduced nausea and toxicity and rapid onset.
Delivery of drugs and vaccines via the nose offer many compelling advantages including reduced nausea and toxicity and rapid onset.
Chronic pain and epilepsy are debilitating disorders that affect millions of individuals in the US and throughout the world.
Wound Management’s FDA approved product has become a primary treatment for all types of wounds and sparked interest in the investment community.
Cervilenz has developed an innovative low cost, single use medical device that accurately measures a pregnant woman’s cervical length, which is the best indicator of preterm birth risk.
In this age where more and more modes of communication are being created, it is natural to find innovative ways to connect health professionals and patients.
Provectus Pharmaceuticals develops a powerful drug pipeline with minimal side effects, including a cancer drug that targets cancer tissue, as well as…
Strategic News Service recently announced that Cynvenio Biosystems has been selected as a 2011 FiReStarter company, to be featured at its annual Future in Review technology conference.
Biovista announced recently that it has entered into a research collaboration agreement with Novartis.
WaferGen Biosystems is a leader in the development, manufacture, and sale of state-of-the-art systems for genome analysis for the life science and pharmaceutical industries.
Bio-Path Holdings has developed a powerful drug delivery technology that utilizes cell-like drug carriers, termed liposomes, which avoid drug breakdown.
Copyright © 2025 | WordPress Theme by MH Themes